Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic Dermatitis

NCT06554847 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic
Eczema, Atopic

Interventions

DRUG: 611
DRUG: Placebo
DRUG: Topical corticosteroid

Sponsor

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.